- Exchange: NYSE MKT LLC
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Neuralstem Inc+ Add to Watchlist
CUR:US2.7100 USD 0.1400 4.91%
As of 15:00:37 ET on 12/22/2014.
Company Profile for Neuralstem Inc (CUR)
Neuralstem Inc. provides medical research services. The Company develops and commercializes clinical treatment for central nervous system diseases. Neuralstem serves the medical field worldwide.
Key Executives for Neuralstem Inc (CUR)
|Karl JoheChairman/Chief Scientific Ofcr||I Richard GarrPresident/CEO/CFO/Gen Counsel|
|Thomas Hazel "Tom"Senior VP:Research||Susan RoushInvestor Relations|